Related Experiment Video
Updated: May 27, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
HDACi: molecular mechanisms and therapeutic implications in the innate immune system
Bandar Ali Suliman1, Dakang Xu, Bryan R G Williams
1College of Applied Medical Sciences, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia.
Abstract:
Histone deacetylase inhibitors (HDACi) are an emerging class of novel anti-cancer drugs that cause growth arrest, differentiation and apoptosis of tumor cells. In addition, many advances have been made in understanding the immunoregulation of Toll-like receptors, NOD-like receptors and interferons that have recently generated new momentum for the study of HDACi in immunity as a whole, and in the regulation of these innate signaling pathways specifically. HDACi have shown promise as new anti-inflammatory and immunosuppressant agents. They have also demonstrated great potency and relative selectivity in various human/animal models of inflammatory diseases. This review focuses on recent progress and the current state of HDACi knowledge, as well as the molecular mechanisms and therapeutic potential of HDACi for the treatment of inflammatory diseases and cancers.
Insights
Histone deacetylase inhibitors (HDACi) show promise in treating cancers and inflammatory diseases. These drugs regulate immune pathways and offer potential anti-inflammatory and immunosuppressant effects.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Background:
- Histone deacetylase inhibitors (HDACi) are novel anti-cancer agents inducing tumor cell apoptosis.
- Advances in understanding Toll-like receptors, NOD-like receptors, and interferons highlight HDACi's role in innate immunity.
- HDACi are emerging as potent anti-inflammatory and immunosuppressant agents.
Purpose of the Study:
- To review recent progress in HDACi knowledge.
- To explore the molecular mechanisms of HDACi in immunity.
- To assess the therapeutic potential of HDACi for inflammatory diseases and cancers.
Main Methods:
- Literature review of recent studies on HDACi.
- Analysis of molecular mechanisms underlying HDACi action in immune regulation.
- Evaluation of preclinical and clinical data on HDACi efficacy.
Main Results:
- HDACi demonstrate significant anti-cancer effects, including growth arrest, differentiation, and apoptosis.
- HDACi modulate innate immune signaling pathways involving TLRs, NLRs, and interferons.
- HDACi show efficacy and selectivity in models of inflammatory diseases.
Conclusions:
- HDACi represent a promising therapeutic strategy for both cancer and inflammatory conditions.
- Further research into HDACi mechanisms can optimize their clinical application.
- HDACi hold significant potential for treating diverse human diseases.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
08:32Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Acute Inflammation I: Inflammatory Response
Inflammatory Bowel Disease III: Crohn's Disease
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Inhibitors of Viral Protein Synthesis